tiprankstipranks
Trending News
More News >
Invizyne Technologies Inc. (IZTC)
NASDAQ:IZTC
US Market

Invizyne Technologies Inc. (IZTC) Similar Stocks

Compare
11 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Invizyne Technologies Inc.
$17.71
Editas Medicine
$1.30
$108.82M
-79.07%
3 Buy
5 Hold
1 Sell
Hold
Intellia Therapeutics
$7.41
$767.06M
-69.47%
14 Buy
4 Hold
1 Sell
Moderate Buy
Crispr Therapeutics AG
$39.30
$3.39B
-35.22%
12 Buy
6 Hold
1 Sell
Moderate Buy
Denali Therapeutics
$12.70
$1.84B
-30.45%
14 Buy
0 Hold
0 Sell
Strong Buy
Twist Bioscience
$38.85
$2.32B
26.63%
5 Buy
1 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IZTC
Invizyne Technologies Inc.
18.61
8.25
79.63%
EDIT
Editas Medicine
1.30
-4.78
-78.62%
NTLA
Intellia Therapeutics
7.41
-15.51
-67.67%
CRSP
Crispr Therapeutics AG
39.30
-19.42
-33.07%
DNLI
Denali Therapeutics
12.70
-5.14
-28.81%
TWST
Twist Bioscience
38.85
9.61
32.87%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis